Pelthos Therapeutics PTHS
NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Inventory Average (2025 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Inventory Average of $23.8 million for Q4 2025.

Pelthos Therapeutics (PTHS) Inventory Average (2025 - 2026) Analysis & Trends

Pelthos Therapeutics' Inventory Average history runs 1 years deep, the most recent figure standing at $23.8 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 213.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 707.10 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 90.57 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 137.65 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 196.36 Mn
10 Pelthos Therapeutics 96.56 Mn 72.00 Mn 21.23 Mn 22.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 22.52 Mn
Dec 31, 2025 23.84 Mn